Influence of oral doxycycline therapy on the diversity and antibiotic susceptibility of human intestinal bifidobacterial population
- PMID: 18397263
- DOI: 10.1111/j.1365-2672.2008.03792.x
Influence of oral doxycycline therapy on the diversity and antibiotic susceptibility of human intestinal bifidobacterial population
Abstract
Aim: To evaluate the influence of doxycycline therapy on the composition and antibiotic susceptibility of intestinal bifidobacteria.
Methods and results: Faecal samples were collected from nine subjects receiving doxycycline therapy and ten control subjects, and analysed for bifidobacteria by culturing and PCR-DGGE (denaturing gradient gel electrophoresis). A marked decrease in the diversity (average number of amplicons detected by PCR-DGGE 0.8 in the antibiotic vs 4.3 in the control group) of Bifidobacterium populations was observed during doxycycline therapy. The proportion of a tetracycline-resistant bifidobacterial population was higher in the antibiotic group than in the control group (83%vs 26%). Based on the tet gene PCR, resistance could be associated with the presence of tet(W). In two subjects, strains representing highly similar genetic fingerprints but different tetracycline susceptibilities were detected. A mutation causing lack of functionality in the tet(W) was observed in one of the susceptible strains.
Conclusions: Doxycycline therapy had a drastic effect on the diversity and tetracycline susceptibility of intestinal Bifidobacterium populations.
Significance and impact of the study: The use of broad-spectrum antibiotics increased the pool of tetracycline-resistant commensal bacteria in the intestine. The detection of resistance genes alone is not sufficient for the evaluation of bacterial antibiotic resistance.
Similar articles
-
Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.Int J Antimicrob Agents. 2007 Mar;29(3):271-80. doi: 10.1016/j.ijantimicag.2006.09.020. Epub 2007 Jan 5. Int J Antimicrob Agents. 2007. PMID: 17207972
-
Analysis of tetracycline resistance tet(W) genes and their flanking sequences in intestinal Bifidobacterium species.J Antimicrob Chemother. 2008 Oct;62(4):688-93. doi: 10.1093/jac/dkn280. Epub 2008 Jul 8. J Antimicrob Chemother. 2008. PMID: 18614524
-
Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products.J Antimicrob Chemother. 2006 Jul;58(1):85-94. doi: 10.1093/jac/dkl197. Epub 2006 May 12. J Antimicrob Chemother. 2006. PMID: 16698847
-
Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria.Food Microbiol. 2007 Sep;24(6):559-70. doi: 10.1016/j.fm.2006.11.001. Epub 2006 Dec 28. Food Microbiol. 2007. PMID: 17418306 Review.
-
Characterisation of Escherichia coli O157 strains from humans, cattle and pigs in the North-West Province, South Africa.Int J Food Microbiol. 2008 Dec 10;128(2):181-8. doi: 10.1016/j.ijfoodmicro.2008.08.011. Epub 2008 Aug 28. Int J Food Microbiol. 2008. PMID: 18848733 Review.
Cited by
-
Doxycycline post-exposure prophylaxis for sexually transmitted infections impacts the gut antimicrobial resistome.Res Sq [Preprint]. 2024 Apr 17:rs.3.rs-4243341. doi: 10.21203/rs.3.rs-4243341/v1. Res Sq. 2024. Update in: Nat Med. 2025 Jan;31(1):207-217. doi: 10.1038/s41591-024-03274-2. PMID: 38699315 Free PMC article. Updated. Preprint.
-
Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome.Nat Med. 2025 Jan;31(1):207-217. doi: 10.1038/s41591-024-03274-2. Epub 2024 Oct 3. Nat Med. 2025. PMID: 39363100 Free PMC article. Clinical Trial.
-
Four recent insights suggest the need for more refined methods to assess the resistogenicity of doxycycline post exposure prophylaxis.Curr Res Microb Sci. 2024 Apr 8;6:100234. doi: 10.1016/j.crmicr.2024.100234. eCollection 2024. Curr Res Microb Sci. 2024. PMID: 38646593 Free PMC article.
-
Bidirectional Interaction between Tetracyclines and Gut Microbiome.Antibiotics (Basel). 2023 Sep 12;12(9):1438. doi: 10.3390/antibiotics12091438. Antibiotics (Basel). 2023. PMID: 37760733 Free PMC article. Review.
-
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.Front Microbiol. 2022 May 31;13:901911. doi: 10.3389/fmicb.2022.901911. eCollection 2022. Front Microbiol. 2022. PMID: 35711781 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials